Zeo ScientifiX (ZEOX) Income from Continuing Operations (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Income from Continuing Operations of 523000.0 for Q2 2026, up 63.04% year-over-year from 320782.4 in Q2 2025, and up 41.1% quarter-over-quarter from 888000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Income from Continuing Operations (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 523000.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 63.04% year-over-year to 523000.0; the TTM figure through Apr 2026 stood at 4205000.0 (up 21.08% YoY), while the FY2025 annual figure was 13689967.0, down 15.51% from the prior year.
- Income from Continuing Operations for Q2 2026 stood at 523000.0, up from 888000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 523000.0 in Q2 2026, with the low at 3019321.0 in Q4 2022.
- The 5-year median for Income from Continuing Operations is 1451521.5 (2022), against an average of 1580622.94.
- Peak annual rise in Income from Continuing Operations reached 79.22% in 2022, while the deepest fall reached 215.12% in 2022.
- Zeo ScientifiX's Income from Continuing Operations stood at 3019321.0 in 2022, then soared by 56.22% to 1322000.0 in 2023, then decreased by 9.46% to 1447000.0 in 2024, then jumped by 51.62% to 700000.0 in 2025, then advanced by 25.29% to 523000.0 in 2026.
- Business Quant data shows ZEOX's Income from Continuing Operations at 523000.0 in Q2 2026, 888000.0 in Q1 2026, and 700000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -174.37 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | -523,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -523,000.00 |
| Jan 31, 2026 | -888,000.00 |
| Oct 31, 2025 | -700,000.00 |
| Jul 31, 2025 | -2.09 Mn |
| Apr 30, 2025 | -1.42 Mn |
| Jan 31, 2025 | -1.28 Mn |
| Oct 31, 2024 | -1.45 Mn |
| Jul 31, 2024 | -1.19 Mn |
| Apr 30, 2024 | -1.58 Mn |
| Jan 31, 2024 | -1.19 Mn |
| Oct 31, 2023 | -1.32 Mn |
| Jul 31, 2023 | -1.62 Mn |
| Apr 30, 2023 | -2.02 Mn |
| Jan 31, 2023 | -2.29 Mn |
| Oct 31, 2022 | -3.02 Mn |
| Jul 31, 2022 | -2.73 Mn |
| Apr 30, 2022 | -1.46 Mn |
| Jan 31, 2022 | -1.69 Mn |
| Oct 31, 2021 | -958,152.00 |
| Jul 31, 2021 | -1.41 Mn |